Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Incorporated in 1995, Gennex Laboratories Limited is a Manufacturer of Pharmaceutical Ingredients. The company manufactures products such as Guaifenesin, Methocarbamol, Fluconazole, Mephenesin, Phenazopyridine Hcl, Melitracen Hcl, Flupentixol Di-Hydrochloride, Chlorphenesin, Allopurinol, among other.
The company's unit is located in IDA Bollaram. Over 70% of the company's business comes from exports to over 50 countries across 5 continents.
Gennex Laboratories has a strong foothold in markets such as LATAM, MENA, SE Asia and the Indian Sub-Continent regions.
| Issue Open | August 5, 2022 - August 19, 2022 |
| Security Name | Gennex Laboratories Limited |
| Issue Size (Shares) | 63,251,500 |
| Issue Size (Amount) | ₹37.95 Crores |
| Issue Price | ₹6 per share |
| Face Value | ₹1 per share |
| Listing At | BSE |
| Terms of Payment | Rs. 1.50/- per Equity Shares to be paid on application and remaining Rs. 4.50/- per on First and Final Call. |
| Entitlement | 1 Rights Equity Shares for every 2 fully paid-up Equity Shares held on the Record Date |
| Record Date | July 22, 2022 |
| Credit of Rights Entitlements | August 4, 2022 |
| Bid/Offer Opens On | August 5, 2022 |
| Renunciation of Rights Entitlements | August 12, 2022 |
| Bid/Offer Closes On | August 19, 2022 |
| Deemed Date of Allotment | August 26, 2022 |
| Credit Date | August 31, 2022 |
| Listing Date | September 2, 2022 |
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 59.08 | 60.17 | 4.04 |
| 31-Mar-22 | 68.21 | 62.6 | 3.92 |
| Amount in ₹ Crore | |||
The Objects of the Issue are:
1. Meeting the Working capital requirement
2. Repayment of borrowings availed by the Company from lenders.
3. Further Investment in Deccan Remedies Ltd.,
4. General Corporate Purposes.
4 3.8 Rating:  Vote Here ... |
Gennex Laboratories Limited
'Akash Ganga' 3rd Floor,
Plot No.144, Srinagar Colony,
Hyderabad-500073, T.S
Phone: +91-40-67334400
Email: info@gennexlab.com
Website: https://www.gennexlab.com/
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: investor@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
The Gennex Laboratories Rights Issue 2022 opens on August 5, 2022, and closes on August 19, 2022.
Gennex Laboratories Rights Issue 2022 Schedule
| Last Date for credit of Rights Entitlements | August 4, 2022 |
| Last Date for renunciation of Rights Entitlements | August 12, 2022 |
| Issue Opening Date | August 5, 2022 |
| Issue Closing Date | August 19, 2022 |
| Date of Allotment (on or about) | August 26, 2022 |
| Date of Credit (on or about) | August 31, 2022 |
| Date of Listing (on or about) | September 2, 2022 |
Gennex Laboratories Rights Issue 2022 price is set at ₹6 per share per equity share.
The eligible shareholders are being offered 1 Rights Equity Shares for every 2 fully paid-up Equity Shares held on the Record Date (July 22, 2022).
The record date for the Gennex Laboratories Rights Issue 2022 is July 22, 2022.
The issue size of Gennex Laboratories Rights Issue 2022 is of 63,251,500 equity shares at ₹6 per share aggregating upto ₹37.95 Crores.
The Letter of Offer for Gennex Laboratories Rights Issue 2022 can be download here.
You can apply for Gennex Laboratories Rights Issue 2022 in two ways:
Steps to apply for Gennex Laboratories Rights Issue 2022 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Gennex Laboratories Rights Issue 2022 using Registrar's website (R-WAP)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
waiting for the email confirmation yet...